BrainStorm Cell Therapeutics
BCLI
#10362
Rank
HK$57.47 M
Marketcap
HK$5.21
Share price
13.56%
Change (1 day)
-71.69%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of September 2025 : HK$3.31 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is HK$3.31 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$5.58 M-43.87%
2023-12-31HK$9.95 M-68.86%
2022-12-31HK$31.97 M-19.25%
2021-12-31HK$39.6 M-29.21%
2020-12-31HK$55.94 M203.62%
2019-12-31HK$18.42 M
2018-12-31N/A
2010-12-31HK$1.06 M-62.84%
2009-12-31HK$2.86 M-16.2%
2008-12-31HK$3.42 M-71.51%
2007-12-31HK$12.01 M37.2%
2006-12-31HK$8.75 M
2006-03-31HK$3.86 M
2004-03-31HK$0.24 M47.42%
2003-03-31HK$0.16 M107.37%
2002-03-31HK$0.07 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
HK$193.88 B 5,840,883.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$9.30 B 280,192.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
HK$0.88 B 26,477.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$51.22 B 1,543,248.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.35 B 10,619.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA